For decades, men with prostate cancer were routinely advised against testosterone replacement therapy (TRT), even if they had ...

A new preclinical study in the journal Signal Transduction and Targeted Therapy describes a very promising therapeutic ...

Immunotherapy: Hope, Hurdles, and a Clever Disguise Immunotherapies stand as one of the most promising paths in modern cancer treatment. Their main goal? To help the body’s own immune system hunt down ...

Frequent nighttime urination and persistent urinary changes may signal prostate cancer, making early PSA screening and timely ...

I f prostate cancer has spread to other areas of your body, your doctor may recommend androgen deprivation therapy (ADT), which halts the production of androgen hormones, especially testosterone.

Bay Area-raised host Ericka Cruz Guevarra brings you context and analysis to make sense of the news. Episodes drop Monday, Wednesday, and Friday. Emma’s Must-Sees See TV Programming Manager Emma ...

Add Yahoo as a preferred source to see more of our stories on Google. An innovative new drug being trialled to tackle certain cancers could also benefit patients with advanced prostate cancer whose ...

Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called metastatic or stage 4 prostate cancer. While most advanced prostate cancer is ...

Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...

The vast majority of people diagnosed with prostate cancer can expect to live long, full lives thanks to improved screening that catches the disease in its early and most treatable stages. But ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...